$1.24
-0.085-6.44%
Last update: Nov 11, 5:55 PM
Autolus Therapeutics PLC
AUTLNASDAQ
Autolus Therapeutics fell 12.0% from $1.50 to $1.32, behind the S&P 500's +9.8%. Its worst day was Jan 12 (−17.1%), and its low came Mar 27 at $1.21.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.30 missed the $-0.23 estimate on $21.2M revenue (est. $22.5M).
−9.3% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the National Institute for
+12.1%, on 32M shares, the year's heaviest volume · S&P 500 +0.9%
Autolus Therapeutics shares rose 12.0%, while the S&P 500 fell 0.4%.
+12.0% · S&P 500 −0.4%
Company expects preliminary unaudited AUCATZYL net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipates full year 2026
−17.1%, the year's worst day · S&P 500 +0.2%
EPS of $-0.34 beat the $-0.38 estimate on $24.3M revenue (est. $23.2M).
−6.2% · S&P 500 −1.7%
EPS of $-0.27 beat the $-0.27 estimate on $26.2M revenue (est. $26.2M); FY revenue guidance of $120.0M–$135.0M against the $129.5M consensus.
−7.0% · S&P 500 +0.8%
Company reports preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million and gross margin of approximately 35% year-to-dateFY 2026 sales guidance increased to $140 – $150 million, from $120 – $135
+22.1%, the year's best day · S&P 500 +1.4%
EPS of $-0.15 beat the $-0.19 estimate on $45.7M revenue (est. $41.1M); FY revenue guidance of $140.0M–$150.0M against the $140.3M consensus.
+12.6% · S&P 500 −0.3%
Autolus Therapeutics closed at its highest level of the year, 69.3% above where the year started.
+10.9% · S&P 500 +0.2%
EPS of $-0.21 missed the $-0.18 estimate on $41.2M revenue (est. $39.8M); FY revenue guidance of $150.0M against the $149.5M consensus.
0.0% · S&P 500 −0.4%
Where it ended: a close of $1.32 on Nov 10, 2026.
Nothing in the past 12 months.
All AUTL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AUTL and SPY from Benzinga historical bars. Not investment advice.
